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Functional overlap among distinct G1/S 
inhibitory pathways allows robust G1 arrest 
by yeast mating pheromones
Patricia A. Pope and Peter M. Pryciak
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 
Worcester, MA 01605
ABSTRACT In budding yeast, mating pheromones arrest the cell cycle in G1 phase via a 
pheromone-activated Cdk-inhibitor (CKI) protein, Far1. Alternate pathways must also exist, 
however, because deleting the cyclin CLN2 restores pheromone arrest to far1∆ cells. Here we 
probe whether these alternate pathways require the G1/S transcriptional repressors Whi5 
and Stb1 or the CKI protein Sic1, whose metazoan analogues (Rb or p27) antagonize cell 
cycle entry. Removing Whi5 and Stb1 allows partial escape from G1 arrest in far1∆ cln2∆ cells, 
along with partial derepression of G1/S genes, which implies a repressor-independent route 
for inhibiting G1/S transcription. This route likely involves pheromone-induced degradation 
of Tec1, a transcriptional activator of the cyclin CLN1, because Tec1 stabilization also causes 
partial G1 escape in far1∆ cln2∆ cells, and this is additive with Whi5/Stb1 removal. Deleting 
SIC1 alone strongly disrupts Far1-independent G1 arrest, revealing that inhibition of B-type 
cyclin-Cdk activity can empower weak arrest pathways. Of interest, although far1∆ cln2∆ 
sic1∆ cells escaped G1 arrest, they lost viability during pheromone exposure, indicating that 
G1 exit is deleterious if the arrest signal remains active. Overall our findings illustrate how 
multiple distinct G1/S-braking mechanisms help to prevent premature cell cycle commitment 
and ensure a robust signal-induced G1 arrest.
INTRODUCTION
Cell cycle progression in all organisms is regulated by both internal 
and external cues. In eukaryotes, the G1 phase of the cell cycle 
provides a critical period in which cells monitor whether conditions 
are appropriate for entry into a new division cycle (Morgan, 2007). 
Signals that control this decision include positive and negative 
growth factors, differentiation triggers, nutrient levels, and environ-
mental stresses. These regulatory signals either promote or prevent 
the transition from a stable G1 state to a new round of DNA synthe-
sis and mitosis. Often, cells become insensitive to these regulatory 
signals once they initiate the G1/S transition, establishing a cell 
cycle commitment phenomenon known as Start in yeast and the 
Restriction Point in animal cells (Hartwell et al., 1974; Pardee, 1974; 
Cross, 1995; Blagosklonny and Pardee, 2002). Accordingly, signals 
that influence cell cycle entry generally affect the molecular machin-
ery that controls the G1/S transition. In all eukaryotes cell cycle tran-
sitions are promoted by cyclin-dependent kinases (Cdks), as well as 
by coordinate changes in gene expression, and these promoting 
factors are often held in check by inhibitory molecules to ensure that 
cell cycle progression is carefully controlled (Morgan, 2007). The 
overall architecture of the G1/S regulatory network is strongly con-
served throughout eukaryotes, although some of the individual 
components may have evolved separately in yeasts versus animals 
(Cross et al., 2011).
In the budding yeast Saccharomyces cerevisiae, a single Cdk, 
Cdc28, associates with nine different cyclins that help drive distinct 
cell cycle events (Bloom and Cross, 2007). The transition from G1 to 
S phase is predominantly controlled by the G1 cyclin Cln3 along 
with two G1/S cyclins, Cln1 and Cln2, whereas the subsequent 
events of DNA synthesis and mitosis (in S and M phases) are driven 
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unclear whether this inhibited transcriptional state is a cause or 
an effect of G1 arrest.
Here we report that the CKI Sic1 is strongly required for arrest in 
the absence of Far1, although not when Far1 is present. The tran-
scriptional repressors Whi5 and Stb1 also contribute to Far1-inde-
pendent arrest, in a manner that is additive with the pheromone-in-
duced degradation of Tec1, a transcriptional activator of CLN1. Our 
results reveal that multiple, functionally overlapping regulatory cir-
cuits control the sensitivity of the G1/S transition to the pheromone 
arrest signal. Collectively these multiple pathways provide robust-
ness to the G1 arrest response, which may help to ensure that com-
mitment to cell cycle entry occurs decisively rather than tentatively.
RESULTS
Studying Far1-independent G1 arrest using synchronous 
cultures
To test the contribution of various regulatory factors to pheromone 
arrest in both the presence and absence of Far1, we used synchro-
nous cultures to measure the duration of G1 phase. The essential 
cell cycle gene CDC20 was placed under control of a regulated pro-
moter (PGAL1), allowing cells to be arrested in M phase and then re-
leased in the presence or absence of pheromone. Cell cycle pro-
gression was monitored by measuring DNA content (using flow 
cytometry) and/or by scoring budding. This approach offered three 
useful features: 1) by measuring G1 duration, we could detect even 
relatively subtle and temporary effects on the G1/S transition; 2) by 
using synchronized cells, we could readily assess the uniformity of 
phenotypes; and 3) we could distinguish specific effects of phero-
mone on G1 arrest from effects on other cell cycle stages or cell vi-
ability (which will become important later).
In this experimental context (Figure 1A), most cells finish mito-
sis and enter G1 (i.e., 1C DNA) by 30–60 min after release from the 
M-phase block and then begin a new round of DNA synthesis 
roughly 30 min later (at 90 min). If pheromone is added, wild-type 
cells complete mitosis and then arrest in G1 (for >3 h). To compare 
multiple different strains and replicate experiments, we plotted the 
percentage of cells with 2C DNA content as a function of time 
(Figure 1B). Generally, M-phase–arrested cultures were 80–90% 
2C, and by 60 min after release they had cycled back to G1 and 
were predominantly 1C (i.e., only 10–15% 2C). As expected, far1∆ 
cells did not arrest in G1 in the presence of pheromone (Figure 
1B). (In addition, with or without pheromone, they showed an ac-
celerated return to the 2C state after completing mitosis, consis-
tent with previous findings that Far1 can alter the timing of the 
G1/S transition even without pheromone treatment; Alberghina 
et al., 2004.) In contrast, when far1∆ cln2∆ cells were released in 
the presence of pheromone, they remained in G1 for an extended 
period (Figure 1B). This arrest was not as strong as in wild-type or 
FAR1 cln2∆ strains, as evidenced by the gradual increase in cells 
with 2C DNA content beginning at 120–150 min after release. 
Thus G1 arrest in the far1∆ cln2∆ cells is partially leaky, but phero-
mone clearly imposes a durable G1 delay that affects the majority 
of cells in the culture.
Separately, we tested how Far1 affects the window of time in 
which cells commit to a new division cycle (Figure 1C). After release 
of cultures from the M-phase block, aliquots were removed at inter-
vals and treated with pheromone to test whether the cells could still 
arrest in G1 or were already committed to division. In wild-type and 
cln2∆ strains, cells transitioned from fully uncommitted (>95% arrest) 
to substantially committed (<65% arrest) between the 45- and 
60-min time points. In the far1∆ cln2∆ strain, two differences were 
evident (Figure 1C). First, the commitment point occurred roughly 
by six B-type cyclins (Clb1–Clb6). The decision of yeast cells to enter 
a new cell cycle can be profoundly influenced by the presence of an 
external cue known as mating pheromone, which promotes fusion 
of two haploid mating partner cells (Hartwell, 1973). During this 
mating reaction, pheromone activates an intracellular signaling 
pathway that arrests the cell cycle in G1 phase, before Start (Dohlman 
and Thorner, 2001; Bardwell, 2005). An important factor in this G1 
arrest pathway is the protein Far1, as far1∆ cells do not arrest in re-
sponse to pheromone (Chang and Herskowitz, 1992). Far1 is be-
lieved to be a Cdk inhibitor (CKI) protein that blocks the activity of 
Cln-Cdc28 complexes and thereby prevents progression through 
Start (Peter et al., 1993; Peter and Herskowitz, 1994; Tyers and 
Futcher, 1993; Jeoung et al., 1998), although some findings conflict 
with this interpretation (Gartner et al., 1998). Of note, however, in 
some circumstances Far1 is dispensable for G1 arrest. For example, 
removing the G1/S cyclin Cln2 from far1∆ cells (i.e., far1∆ cln2∆) re-
stores pheromone-induced G1 arrest (Chang and Herskowitz, 1992; 
Cherkasova et al., 1999). Thus, even in the complete absence of 
Far1, pheromone signaling still can interfere with the ability of cells 
to pass Start and enter a new division cycle. Despite early recogni-
tion of this fact, the molecular mechanisms responsible for Far1-
independent arrest remain obscure.
In this study, we probe the Far1-independent arrest mecha-
nisms more closely in order to better understand how pheromone 
signaling regulates G1 arrest and provide more general insights 
into the multiplicity of factors that control cell cycle commitment 
decisions. We reasoned that pheromone arrest might involve 
known negative regulators of the G1/S transition that act as 
“brakes” to antagonize cell cycle entry in many eukaryotes 
(Morgan, 2007). One such negative regulator is the CKI protein 
Sic1 (Donovan et al., 1994; Schwob et al., 1994), which is function-
ally analogous to the mammalian CKI p27(Kip1) (Sherr and Roberts, 
1999). During G1, these CKI proteins inhibit Cdks bound to B-type 
cyclins and thereby prevent premature entry into S phase. This in-
hibition is eventually released in late G1, when cyclin-Cdk activity 
reaches levels sufficient to target the CKI for degradation (Schwob 
et al., 1994; Nash et al., 2001; Cross et al., 2007; Koivomagi et al., 
2011). Another mode of negative regulation involves transcrip-
tional repression of genes expressed at the G1/S boundary. In ani-
mal cells, transcription of G1/S genes is activated by the E2F family 
of heterodimeric transcription factors and repressed by members 
of the retinoblastoma protein (Rb) family (Frolov and Dyson, 2004; 
van den Heuvel and Dyson, 2008). Yeast cells have an analogous 
system (Bahler, 2005; Wittenberg and Reed, 2005), in which G1/S 
transcription is driven by two heterodimeric transcription factors 
called SBF (Swi4-Swi6) and MBF (Mbp1-Swi6) and is inhibited in 
early G1 by the repressors Whi5 and Stb1 (Koch et al., 1996; 
Costanzo et al., 2003, 2004; de Bruin et al., 2004, 2008; Bean 
et al., 2005). These repressors block the activity of DNA-bound 
SBF and MBF in part by recruiting histone deacetylases (Huang 
et al., 2009; Takahata et al., 2009; Wang et al., 2009); in late G1, 
they are dissociated via Cdk phosphorylation, allowing SBF/
MBF-dependent transcription to ensue (Costanzo et al., 2004; 
de Bruin et al., 2004; Wagner et al., 2009; Doncic et al., 2011). 
Important targets of SBF and MBF include the G1/S cyclin genes 
CLN1 and CLN2, which yields increased G1/S Cdk activity, 
thereby creating a positive feedback loop that helps to ensure a 
decisive G1/S transition (Cross and Tinkelenberg, 1991; Dirick 
and Nasmyth, 1991; Skotheim et al., 2008). MBF/SBF-regulated 
genes are not expressed in pheromone-arrested cells, regard-
less of whether the arrest is Far1 dependent or independent 
(Wittenberg et al., 1990; Cherkasova et al., 1999), but it was 
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relies on control of G1/S transcription, we probed the role of Whi5 
and Stb1, the repressors of the G1/S transcription factors SBF and 
MBF. Deletion of STB1 alone produced no discernible change in 
either FAR1 cln2∆ or far1∆ cln2∆ strains (Figure 2, A–D). Deletion of 
WHI5 had no effect in FAR1 cln2∆ cells (Figure 2A), but in far1∆ 
cln2∆ cells (Figure 2C) it allowed a greater fraction of cells to escape 
G1 arrest (e.g., 38 vs. 24% 2C at 240 min). Assays using bud emer-
gence as a marker of cell cycle progression yielded largely similar 
results, except that the escape phenotype caused by removing 
Whi5 was even more evident, and there was further enhancement 
when both Whi5 and Stb1 were removed (Figure 2D). Thus the tran-
scriptional repressors contribute to Far1-independent G1 arrest. 
Despite these effects, the escape phenotypes were only partial, in 
that pheromone still imposed a significant G1 delay in the majority 
of cells.
We also tested the role of Mbp1, which is the DNA-binding com-
ponent of the MBF heterodimer (Bahler, 2005). Although Mbp1 is 
required for transcriptional activation by MBF, it is also required for 
full repression of MBF-bound genes (Koch et al., 1993; Bean et al., 
2005; de Bruin et al., 2006). We found that removing Mbp1 from 
far1∆ cln2∆ cells caused a more complete arrest rather than in-
creased escape (Figure 2E), suggesting that either its role as an 
15 min earlier, as judged by the time at which 50% of cells still arrest. 
Second, the transition was less sharp, as evidenced by a more grad-
ual increase in the fraction of cells that could not arrest. Together 
these data indicate that Far1 makes the arrest mechanism more po-
tent, as it allows pheromone to arrest cells that have advanced 
closer to Start, and also more robust, as the arrest is more uniform in 
FAR1 cln2∆ than far1∆ cln2∆ cells. These findings complement a 
study in which the commitment point could be delayed by a stabi-
lized form of Far1 (Doncic et al., 2011). Nevertheless, despite these 
clear effects of Far1, our results show that a commitment point still 
exists in the absence of Far1, albeit one that is advanced so that the 
time window in which arrest can be imposed is more limited. In ex-
periments to follow, the Far1-independent arrest phenotype in far1∆ 
cln2∆ strains serves as sensitized setting in which to test the contri-
bution of other factors that affect the G1/S transition.
Role of G1/S transcriptional repressors in G1 arrest
Previous studies found that expression of G1/S transcripts is inhib-
ited in pheromone-arrested cells (Wittenberg et al., 1990), even 
when the arrest is Far1 independent (Cherkasova et al., 1999). Yet it 
was unclear whether this inhibition is a cause or a reflection of the 
G1 arrest. Hence, to determine whether Far1-independent arrest 
FIGURE 1: Far1-independent arrest and cell cycle commitment in synchronous cultures. (A) Example of synchronous cell 
cycle progression and G1 arrest. A PGAL1-CDC20 strain was arrested in M phase (by transfer to glucose medium) and 
then released (by return to galactose medium) in the presence or absence of α factor. At the times indicated, DNA 
content of cells was assayed by flow cytometry. In each histogram, the horizontal axis represents fluorescence, and the 
vertical dimension shows the number of cells. Bottom, the range of fluorescence values used to calculate the proportion 
of cells with replicated DNA (percentage 2C) in subsequent figures. This example uses a cln2∆ strain (YPAP165). (B) The 
ability of α factor to halt cell cycle progression was analyzed for four strains, using the PGAL1-CDC20 method described 
in A. Graphs show mean ± range (n = 2) for wild-type and far1∆ or mean ± SD (n = 4) for cln2∆ and far1∆ cln2∆ strains.
(C) Cell cycle commitment occurs earlier in the absence of Far1. After releasing PGAL1-CDC20 cultures from the M-phase 
block, aliquots were removed at 15-min intervals and treated with pheromone. At 120 min, cells were scored for 
whether they had arrested in G1 (unbudded cells) or entered the cell cycle (budded). Graphs show mean ± SEM (n = 5); 
asterisks indicate points where the difference between far1∆ cln2∆ and cln2∆ was deemed statistically significant 
(p < 0.025; two-tailed unpaired t test).
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et al., 2009; Wang et al., 2009). To determine whether the reduced 
arrest proficiency of the far1∆ cln2∆ whi5∆ strain was due to the loss 
of Rpd3 recruitment, we tested far1∆ cln2∆ rpd3∆ strains (Figure 
2F). In fact, deletion of Rpd3 did not increase escape from G1 arrest 
and instead seemed to make G1 exit even slower, although this may 
reflect a slightly decreased growth rate of rpd3∆ mutants. Further-
more, Rpd3 is not required for the G1 arrest role of Whi5, because 
removing Whi5 from the far1∆ cln2∆ rpd3∆ strain still led to 
increased escape, indicating that the whi5∆ phenotype cannot be 
attributed solely to a defect in Rpd3 recruitment.
activator outweighs its role as a repressor in this setting or its re-
moval allows stronger gene repression during pheromone treat-
ment, possibly due to increased binding of SBF to MBF target genes 
(de Bruin et al., 2006). Deleting WHI5 from these far1∆ cln2∆ mbp1∆ 
cells allowed increased escape from G1 arrest (Figure 2E), with an 
especially strong difference (i.e., with vs. without Whi5), although 
the effect remained partial such that the majority of cells still 
arrested.
Whi5 and Stb1 repress transcription in part through the recruit-
ment of the histone deacetylase Rpd3 (Huang et al., 2009; Takahata 
FIGURE 2: Partial role for transcriptional repressors in Far1-independent arrest. (A) Removal of Whi5 and/or Stb1 does 
not affect G1 arrest when Far1 is present. PGAL1-CDC20 strains in the FAR1 cln2∆ background were arrested in M phase 
and released in the presence or absence of pheromone. Cell cycle progression and G1 arrest were measured by the 
flow cytometry assay of DNA content. Graphs show mean ± SEM (n = 4–8). (B) The strains in A were tested for G1 arrest 
by the budding assay. Budding was scored 120 min after release from M-phase arrest in the presence of α factor. Bars, 
mean ± SEM (n = 3–4). (C) Removal of Whi5 partially compromises Far1-independent arrest. Cell cycle progression and 
G1 arrest were measured in far1∆ cln2∆ strains by the DNA assay. Graphs show mean ± SEM (n = 4–8). (D) Strains from 
C were tested for G1 arrest by the budding assay as in B. Bars show mean ± SEM (n = 6). (E) Mbp1 is not required for 
Far1-independent arrest or for the role of Whi5. G1 arrest was measured by the DNA (left) and budding (right) assays. 
Data points, mean ± SEM (n = 3). (F) Rpd3 is not required for the role of Whi5. Graphs show mean ± SEM (n = 4) for 
far1∆ cln2∆ and far1∆ cln2∆ rpd3∆ or mean ± range (n = 2) for far1∆ cln2∆ rpd3∆ whi5∆.
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SBF and/or MBF at the G1/S transition (Bean et al., 2005; de Bruin 
et al., 2006; Eser et al., 2011). For comparison, we also monitored a 
gene expressed at the earlier M/G1 boundary (SIC1). We first con-
ducted single-time-course experiments for eight different strains, in 
which we measured transcript levels at numerous time points in syn-
chronous cultures (Figure 3). Then we analyzed the most informative 
time points in multiple independent trials (Figure 4).
In cells released from mitosis without pheromone, the M/G1 and 
G1/S transcripts peaked at 30 and 60 min, respectively (Figure 3). 
This agrees with the timing of DNA synthesis and budding (which 
begin at 60–90 min). Adding pheromone prevented the G1/S peak 
in FAR1 cln2∆ cells, and instead these transcripts declined to a mini-
mum at 60 min and remained low for up to 4 h (Figure 3). In the 
absence of Far1 (far1∆ cln2∆ cells), pheromone still inhibited the 
G1/S peak, but after 60 min these transcripts gradually increased, 
reaching levels that were higher than the corresponding FAR1 cln2∆ 
cells but below the peak levels in untreated cells. This gradual in-
crease is consistent with the leaky arrest phenotype of far1∆ cln2∆ 
Collectively these results show that Whi5 and Stb1 are not re-
quired for the strong G1 arrest seen when Far1 is present, but they 
contribute to the weaker G1 arrest observed in cells that lack Far1. 
Even so, their removal from far1∆ cln2∆ cells causes only a partial 
defect in G1 arrest, indicating that pheromone signaling can still in-
hibit the G1/S transition in the absence of both Far1 and these tran-
scriptional repressors.
Loss of repressors only partially derepresses transcription
We considered two possible explanations for why removing the 
transcriptional repressors did not fully eliminate G1 arrest in far1∆ 
cln2∆ cells: 1) pheromone signaling might still be able to inhibit 
G1/S transcription even without the repressors; and 2) the G1/S 
transcripts could be fully derepressed, but pheromone signaling 
might exert nontranscriptional effects that inhibit exit from G1. To 
test these possibilities, we analyzed G1/S transcript levels via real-
time quantitative PCR (RT-qPCR). We chose five representative 
genes (CLN1, YOX1, POL1, RNR1, and CDC21) that are induced by 
FIGURE 3: Effects of Far1, Whi5, and Stb1 on G1/S mRNA levels. The effects of Whi5 and Stb1 on G1/S transcript 
levels were measured in FAR1 cln2∆ (left) and far1∆ cln2∆ (right) backgrounds. PGAL1-CDC20 strains were arrested in M 
phase and released with or without α factor. At 30-min intervals, mRNA levels were measured by RT-qPCR (see Materials 
and Methods). Five G1/S transcripts (CLN1, YOX1, RNR1, POL1, and CDC21) and one M/G1 transcript (SIC1) were 
monitored. mRNA levels at each time point were plotted relative to the levels present in the M-phase–arrested cultures 
(t = 0). The drop in G1/S transcript levels from M phase (t = 0) to G1 (t = 30 min) was unexpected because these genes 
are not believed to be active during mitosis; this behavior might reflect imperfect synchronization in M phase, or it 
might indicate that maximal repression of these genes requires nuclear localization of Swi6 and DNA binding by SBF/
MBF, which are inhibited by high Cdk activity in M phase (Sidorova et al., 1995; Koch et al., 1996; Queralt and Igual, 
2003; Geymonat et al., 2004). See Figure 4 for further analyses.
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cells. As expected for transcriptional repressors, removal of Whi5 
and/or Stb1 allowed G1/S transcripts to start increasing earlier and/
or to reach elevated levels in pheromone-treated cells. More specifi-
cally, the stb1∆ mutation seemed to reduce the pheromone-medi-
ated decrease in all transcripts upon release from the mitotic block, 
whereas the whi5∆ mutation was more selective for specific tran-
scripts. Nevertheless, in the absence of either repressor, or both si-
multaneously, pheromone still interfered with peak gene expression. 
These patterns of partial derepression were seen in both FAR1 cln2∆ 
and far1∆ cln2∆ backgrounds, although inhibition by pheromone 
was generally more potent and durable when Far1 was present. 
Clearly, pheromone signaling can prevent peak G1/S transcription 
even without Whi5 and Stb1.
For further analysis we performed multiple repetitions of each 
time course experiment and then measured mRNA levels at 60 min 
after release from M phase (Figure 4), as this was when expression 
peaked in the absence of pheromone. Without pheromone, G1/S 
transcripts reached roughly the same peak level in all strains (Figure 
4), consistent with previous findings that Whi5 and Stb1 only slightly 
affect peak expression (Costanzo et al., 2003, 2004; de Bruin et al., 
2004, 2008; Takahata et al., 2009). However, derepression was 
clearly evident in the pheromone-treated samples, as G1/S tran-
scripts were no longer fully repressed when Whi5 and/or Stb1 were 
absent. Of note, however, even in the absence of both Whi5 and 
Stb1, G1/S transcript levels in pheromone-treated cells did not 
reach the maximum seen in untreated samples. Therefore inactiva-
tion of these repressors is not sufficient for full expression of G1/S 
transcripts, as pheromone signaling can still prevent their full ex-
pression. For several mRNAs the highest levels were seen in the 
far1∆ cln2∆ whi5∆ and far1∆ cln2∆ stb1∆ whi5∆ strains, which agrees 
with the finding that these strains have the strongest G1 escape 
phenotype, yet the ability of pheromone to prevent peak expres-
sion in these strains also agrees with the finding that even the stron-
gest G1 escape phenotypes were partial.
The mRNA analyses revealed striking synergy between Far1 and 
Whi5 (Figure 4). That is, for several genes there was an additive ef-
fect of removing both proteins (i.e., far1∆ cln2∆ whi5∆), whereas 
pheromone treatment could still exert a strong repressive effect if 
either one was present (i.e., FAR1 cln2∆ whi5∆ or far1∆ cln2∆ WHI5). 
Again, this correlates with the arrest behavior, in that removing Whi5 
caused a notable escape phenotype only when Far1 was absent. By 
contrast, the derepression caused by removing Stb1 was not further 
enhanced when Far1 was also removed (compare FAR1 cln2∆ stb1∆ 
with far1∆ cln2∆ stb1∆), and the additive relationship between Far1 
and Whi5 did not require Stb1 (compare FAR1 cln2∆ stb1∆ whi5∆ 
with far1∆ cln2∆ stb1∆ whi5∆). Together these results suggest that 
Far1 and Whi5 contribute additively to transcriptional repression, 
with a corresponding additive effect on G1 arrest. Because Far1 is 
believed to inhibit Cln-Cdk activity (Peter et al., 1993; Peter and 
Herskowitz, 1994; Tyers and Futcher, 1993; Jeoung et al., 1998), the 
finding that it contributes to transcriptional repression even in the 
absence of Whi5 and Stb1 suggests that Cdk activity promotes 
G1/S transcription by additional mechanisms distinct from repressor 
displacement (see Discussion).
The CLN1 transcription factor Tec1 antagonizes G1 arrest
One route by which pheromone might inhibit G1/S transcription 
could involve the ability of the pheromone-activated mitogen-acti-
vated protein kinase (MAPK) Fus3 to trigger degradation of the tran-
scription factor Tec1 (Bao et al., 2004; Bruckner et al., 2004; Chou 
et al., 2004). Because Tec1 positively regulates CLN1 expression 
FIGURE 4: Loss of repressors only partially derepresses 
transcription. G1/S transcripts were assayed at a fixed time 
corresponding to the transition from G1 to S phase. The PGAL1-
CDC20 arrest/release experiments shown in Figure 3 were repeated 
three times, and mRNA levels were measured before and 60 min 
after release in either the presence or absence of α factor. Bars, 
mRNA levels (mean ± SD; n = 3) at the 60-min time points, expressed 
relative to the levels in the M-phase–arrested cells. The effects of 
Whi5 and Stb1 were compared in FAR1 cln2∆ (left) and far1∆ cln2∆ 
(right) backgrounds. Statistical analysis of all 120 pairwise 
comparisons, using the Benjamini–Hochberg false discovery rate 
method, is provided in Supplemental Table S1. The most pertinent 
points are 1) the inhibition by α factor is statistically significant 
(q < 0.05) for each of the eight individual genotypes and 2) the 
derepression due to removal of Whi5/Stb1 is significant in most 
cases except for comparisons involving the far1∆ cln2∆ whi5∆ strain, 
for which greater variability prevents a firm conclusion, but the 
effect of Whi5 is separately supported by comparing far1∆ cln2∆ 
stb1∆ with far1∆ cln2∆ stb1∆ whi5∆ (e.g., q = 0.007 for CLN1 
mRNA).
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Related phenotypes were observed 
when cell cycle entry was analyzed in syn-
chronous PGAL1-CDC20 cultures. Namely, 
extra Tec1 or stabilized Tec1-T273M caused 
only a mild escape from G1 arrest in FAR1 
cln2∆ cells but caused a substantial escape 
in far1∆ cln2∆ cells and had an additive ef-
fect with Whi5/Stb1 removal, such that the 
majority of far1∆ cln2∆ stb1∆ whi5∆ cells 
now escaped G1 arrest (Figure 5B). This ad-
ditive effect was also clearly evident when 
the G1/S transition was monitored using 
DNA content (Figure 5C), for which we 
found that the degree of G1 escape was 
maximal upon the simultaneous removal of 
Whi5/Stb1 and stabilization of Tec1. It is not 
known why an extra copy of TEC1 mimics 
TEC1-T273M more closely in synchronous 
assays (Figure 5B) than in halo assays (Figure 
5A), but it is possible that the synchroniza-
tion protocol imparts greater sensitivity to 
TEC1 dose because of the transfer to glu-
cose-free media, which increases expression 
of TEC1 and Tec1-dependent genes (Cullen 
and Sprague, 2012). Nonetheless, the simi-
lar effects of both extra and stabilized Tec1 
agree with the notion that pheromone arrest 
depends in part on blocking Tec1 accumula-
tion. Taken together, our results indicate 
that Far1-independent arrest is promoted 
by two parallel pathways that act additively 
to reduce G1/S gene expression: Whi5/
Stb1-mediated repression of SBF/MBF 
genes, and pheromone-triggered degrada-
tion of the CLN1 transcription factor Tec1.
Finally, to assess how strongly Far1-inde-
pendent pathways can contribute to arrest 
in an otherwise wild-type cell, we tested the 
same TEC1 plasmids in a strain with intact 
copies of both FAR1 and CLN2. Remarkably, 
the Tec1-T273M mutant caused much stron-
ger pheromone resistance in FAR1 CLN2 
cells than in FAR1 cln2∆ cells (Figure 5, A, leftmost vs. rightmost 
columns, and B, right). Thus the same pathway can promote arrest 
in both far1∆ cln2∆ cells and wild-type cells. In addition, these re-
sults reveal an interesting parallel between Far1-dependent and 
Far1-independent pathways, as the pheromone resistance pheno-
type of either far1∆ or TEC1-T273M is suppressed by removing 
Cln2.
Sic1 plays a strong role in Far1-independent arrest
Another regulator of the G1/S transition is the protein Sic1, a CKI 
that inhibits S-phase cyclin-Cdks during early G1 and is inactivated 
in late G1 via phosphorylation by G1/S cyclin-Cdks. Because of its 
role as an antagonist of the G1/S transition, we tested whether Sic1 
is involved in the Far1-independent arrest by pheromone (Figure 6). 
(These experiments exclusively used the budding assay because the 
sic1∆ mutation caused extremely broad DNA flow cytometry pro-
files in PGAL1-CDC20 strains, which obscured the analysis.) Indeed, 
although deleting SIC1 had no effect on G1 arrest when Far1 was 
present (Figure 6A), it had a substantial effect on Far1-independent 
arrest (Figure 6B). That is, in far1∆ cln2∆ sic1∆ cells the ability of 
(Madhani et al., 1999; Bruckner et al., 2004), its pheromone-induced 
degradation could indirectly dampen G1/S transcripts that are tar-
gets of Cln1-Cdc28 (Eser et al., 2011), which might be especially 
consequential in cln2∆ cells. To explore these notions, we first used 
halo assays to monitor how Tec1 affects growth arrest in both the 
presence and absence of Far1 (Figure 5A). We compared plasmids 
containing an extra copy of wild-type Tec1 or a mutant form, Tec1-
T273M, which is resistant to pheromone-induced degradation (Bao 
et al., 2004; Bruckner et al., 2004; Chou et al., 2004) and disrupts the 
ability of pheromone to inhibit CLN1 expression (Bruckner et al., 
2004). We observed a gradual reduction in arrest proficiency as 
more regulatory pathways were inactivated. Specifically, the Tec1-
T273M mutant caused only a mild arrest defect in FAR1 cln2∆ cells 
(visible as a reduction in halo clarity and sharpness), but it caused a 
strong arrest defect in far1∆ cln2∆ cells, which was even stronger 
when Whi5/Stb1 were also absent (Figure 5A). By comparison, the 
extra copy of wild-type Tec1 had a milder effect in these assays. 
Overall the results suggest that pheromone inhibition of Tec1 activ-
ity becomes especially important when the Far1-dependent path-
way is disrupted.
FIGURE 5: The CLN1 transcription factor Tec1 antagonizes Far1-independent G1 arrest. 
(A) Empty vector or TEC1 plasmids (pPP681, pPP4042, pPP4043) were introduced into the 
indicated strains (PPY1716, PPY1789, PPY1867, YPAP157, YPAP161). Cells were spread on 
selective media (SC –Ura), overlaid with filter disks containing 20 μl of α factor (20 or 100 μM), 
and then incubated at 30°C for 2 d. (B) Empty vector or TEC1 plasmids (pPP680, pPP4050, 
pPP4051) were introduced into the indicated PGAL1-CDC20 strains (PPY2014, PPY2063, 
YPAP165, YPAP167, YPAP171). Cells were released from the mitotic block into medium 
containing α factor, and the percentage of cells that escaped G1 arrest was measured by 
scoring budding after 120 min. Bars, mean ± range; the two strains at right (n = 3) were assayed 
together in a set of experiments separate from the four strains at left (n = 2–5). In each strain, 
differences between vector and TEC1 (wild type and T273M) sets were ranked significant by a 
two-tailed unpaired t test (from left to right, p = 0.008, 0.009, 0.014, 0.002, 0.005, 0.0002). 
(C) PGAL1-CDC20 strains (PPY2014, YPAP171) contained empty vector or a TEC1-T273M plasmid 
(pPP680, pPP4051). Cells were released from the mitotic block into medium containing α factor, 
and DNA content was monitored at the indicated times. Graphs show mean ± range of two 
separate experiments (some error bars are smaller than symbols).
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G1 arrest failure can compromise cell viability
Although removing Sic1 allowed far1∆ cln2∆ cells to escape phero-
mone-induced G1 arrest more readily, it appeared to cause en-
hanced sensitivity to pheromone when growth arrest was measured 
by a long-term halo assay (Figure 7A). This paradox led us to con-
sider the possibility that the failure of these cells to arrest in G1 
causes reduced viability during continuous incubation with phero-
mone. Therefore we assayed cell viability in asynchronous cultures 
treated with pheromone for various times (Figure 7B). Wild-type 
strains maintained viability for several hours, but the far1∆ cln2∆ 
sic1∆ strain showed a clear loss of viability after only a short period 
(2–4 h). This reduced viability was not seen in the absence of phero-
mone (legend to Figure 7) or when either Far1 or Sic1 was present 
(i.e., FAR1 cln2∆ sic1∆ or far1∆ cln2∆ SIC1 strains), suggesting that 
it is not the presence or absence of either protein per se but rather 
the rapid escape from G1 that ultimately causes reduced viability in 
the far1∆ cln2∆ sic1∆ strain. Furthermore, simultaneous absence of 
both proteins was tolerated if strains retained CLN2 (i.e., far1∆ sic1∆ 
strains; Figure 7C). Because Cln2 plays a prominent role in blocking 
pheromone response as cells pass Start (Oehlen and Cross, 1994; 
Strickfaden et al., 2007), the combined results suggest that the ob-
served inviability is due to cells exiting G1 without down-regulating 
pheromone signaling.
These implications were further corroborated by other experi-
ments that did not involve Far1, Sic1, or Cln2. In particular, overpro-
duction of the S-phase cyclin Clb5 can override G1 arrest by phero-
mone (Oehlen et al., 1998), and a Cdk-resistant form of the signaling 
protein Ste5 (Ste5-8A) prevents pheromone response from being 
shut down in post-Start cells (Strickfaden et al., 2007). The presence 
pheromone to impose a G1 arrest was strongly disrupted, although 
it was not eliminated. The residual arrest was not eliminated by fur-
ther deletion of WHI5 (Figure 6B), and hence we saw no evidence 
for synergy between Sic1 and Whi5. Furthermore, removing both 
Sic1 and Whi5 in a FAR1 background had no phenotype (Figure 6A). 
Thus removing any two antagonists of the G1/S transition is not 
sufficient to cause a G1 escape phenotype. Instead, this phenotype 
is only seen when combining far1∆ with either whi5∆ or sic1∆ muta-
tions. We conclude that the G1/S-braking mechanism provided by 
Sic1 allows pheromone to activate a weakened G1 arrest response 
when Far1 is absent.
For comparison to the findings with Sic1, we tested another 
antagonist of S- and M-phase cyclins, namely, the APC compo-
nent Cdh1, which inhibits accumulation of B-type cyclins during 
G1 (Visintin et al., 1997; Morgan, 2007). We found that removal of 
Cdh1 in the far1∆ cln2∆ background caused a negligible change 
in G1 escape (Figure 6B), although for unknown reasons we did 
observe an increased escape phenotype in rare isolates (legend 
to Figure 6). Therefore these findings suggest that Far1-indepen-
dent arrest depends more strongly on the inhibitor of Clb-Cdk 
activity (Sic1) than on the inhibitor of Clb protein accumulation 
(Cdh1). Note, however, that we cannot rule out the possibility that 
the absence of Cdh1 was suppressed in our experiments by ecto-
pic expression of its functional relative, Cdc20, which enabled the 
cell synchronization protocol; for example, PGAL1-CDC20 expres-
sion may limit accumulation of the B-type cyclin Clb2, which was 
shown previously to allow premature escape from pheromone ar-
rest in a fraction of cdh1 (hct1-3) mutant cells (Schwab et al., 
1997).
FIGURE 6: Sic1 plays a strong role in Far1-independent arrest. PGAL1-CDC20 strains of the indicated genotypes were 
synchronized and then released into the presence or absence of α factor (αF). Cell cycle progression and G1 arrest was 
assayed by budding. (A, B) Results in the FAR1 cln2∆ and far1∆ cln2∆ backgrounds, respectively. All graphs show the 
mean ± SD (n = 4–6). Note that far1∆ cln2∆ cdh1∆ strains showed phenotypic heterogeneity that was isolate dependent. 
Specifically, we tested 12 isolates: six PGAL1-CDC20 derivatives from each of two independent far1∆ cln2∆ cdh1∆ strains. 
The results shown are an average of three strains (YPAP242, 244, 245) that displayed the majority phenotype seen in 10 
of 12 isolates. In two of 12 isolates, both derived from the same initial far1∆ cln2∆ cdh1∆ parent strain, we observed a 
notable escape phenotype (e.g., for YPAP243, ∼40% budded cells after 120–180 min in α factor). The reason for this 
heterogeneity is unknown, but the observation of the escape phenotype in only a minority of derivatives (2/6) of one 
parent strain and in no derivatives (0/6) of the other suggests that a rare enhancer mutation may be responsible.
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of both features together (i.e., STE5–8A PGPD1-CLB5 double mu-
tants) caused cells to lose viability during pheromone exposure, 
whereas the single mutants did not (Figure 7C), arguing that inviabil-
ity is a specific consequence of allowing pheromone signaling to 
continue in cells that escape the G1 arrest. Taken together, these 
findings illustrate the physiological importance of maintaining a ro-
bust G1 arrest in cells that are still transmitting the arrest signal. 
They also reveal that, under some circumstances, mutations that 
compromise G1 arrest would not be identified using only a growth 
arrest assay (see Discussion).
DISCUSSION
In this study we sought to increase our understanding of the mecha-
nisms that yeast cells use to activate G1 arrest in response to extra-
cellular mating pheromones. Previous findings indicate that this ar-
rest does not absolutely require the pheromone-activated CKI Far1, 
because removal of Cln2 restores pheromone arrest to far1∆ cells. 
Thus here we compared Far1-dependent and Far1-independent 
G1 arrest in terms of their molecular phenotypes and their depen-
dence on other inhibitory factors. We found that Far1 is not abso-
lutely required for establishing a commitment point at Start, but it 
lengthens the time window in which pheromone can block this com-
mitment step. Far1 also makes the G1 arrest process less depen-
dent on other antagonists of the G1/S transition, such as repressors 
of G1/S transcription and inhibitors of S- and M-phase Cdk activity. 
Conversely, these repressors and inhibitors are not absolutely re-
quired for G1 arrest, but they reduce the dependence on Far1. 
Thus G1 arrest is made robust by functional overlap among multiple 
distinct G1/S inhibitory pathways (Figure 8).
In many eukaryotes it is believed that inhibition of G1/S transcrip-
tion by Rb-like repressors and inhibition of S- and M-phase Cdk ac-
tivity by Cip/Kip-like CKIs are key factors that restrain cell cycle entry 
and thereby impose a G1 waiting period (Morgan, 2007). In this 
study we found that pheromone-induced G1 arrest in budding yeast 
can still be imposed in the absence of the transcriptional repressors 
FIGURE 7: Failure to arrest in G1 causes loss of viability during 
pheromone exposure. (A) Removing Sic1 from far1∆ cln2∆ cells 
causes enhanced pheromone sensitivity when measured by a chronic 
growth arrest (halo) assay. Cells were spread on solid growth 
medium, overlaid with filter disks containing 20 μl of α factor 
(20 or 100 μM), and then incubated at 30°C for 2 d. (B) Pheromone 
treatment causes loss of viability in far1∆ cln2∆ sic1∆ cells. 
Asynchronous liquid cultures were incubated with pheromone for 
1–4 h, and then cell viability was measured by plating on medium 
lacking pheromone and counting colony formation (see Materials 
and Methods). Viable cells at each time point were expressed 
relative to the number present before treatment (t = 0). Graphs 
show mean ± range (n = 2). In parallel cultures incubated without 
pheromone, no differences in viability were observed among these 
strains (unpublished data ). (C) Loss of cell viability is a consequence 
of escaping G1 arrest without inhibiting pheromone signaling. 
Asynchronous cultures were incubated with pheromone for 4 h, and 
viable cells were measured and expressed relative to the pretreated 
cultures (t = 0) as in B. Bars, mean ± SD (n = 4). Strains that continue 
dividing in the presence of pheromone (e.g., far1∆) show an 
increased number of viable cells at 4 h compared with pretreated 
culture. See the text for further explanation.
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FIGURE 8: Simple illustration of multiple pathways contributing to 
pheromone arrest. Regulatory effects that inhibit or promote the 
G1/S transition are indicated in red or green, respectively. Dashed 
arrows with question marks emphasize that, although we found roles 
for Whi5/Stb1 and Sic1 in Far1-independent arrest, it is not known 
whether pheromone signaling enhances their inhibitory activity or 
simply depends on their constitutive effects. This simplified view is 
elaborated in greater detail in Supplemental Figure S1, which also 
includes a comparison of expected differences in wild-type, far1∆, and 
far1∆ cln2∆ cells. See the text for further discussion.
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S-phase cyclin Clb5 is expressed from a strong foreign promoter 
(Oehlen et al., 1998; Strickfaden et al., 2007). This view can explain 
the effects of removing Sic1, which directly inhibits Clb5-Cdk activity 
(Schwob et al., 1994). Furthermore, CLB5 is an SBF-regulated gene, 
as are CLN1 and CLN2, which engage in a positive feedback loop 
that enhances their own expression plus other SBF/MBF-dependent 
genes (Cross and Tinkelenberg, 1991; Dirick and Nasmyth, 1991; 
Skotheim et al., 2008). Thus, in far1∆ cln2∆ cells, levels of CLN1 and 
CLB5 expression may determine whether sufficient Clb5-Cdk activ-
ity accumulates to pass Start, and hence their increased expression 
upon removal of Whi5/Stb1 and/or addition of stabilized Tec1 may 
cause the escape phenotype. In far1∆ single mutants, the presence 
of Cln2 may tip the balance in favor of Start by a mix of several ef-
fects: 1) it might simply increase the total cyclin dosage, equal to an 
extra copy of CLN1; 2) Cln2 might be a more effective promoter of 
Start than Cln1 (Tyers and Futcher, 1993), perhaps by providing 
greater Cdk activity toward key substrates like Whi5 and Sic1; and 3) 
Cln2 counteracts pheromone arrest by directly inhibiting phero-
mone signaling, and it does so more potently than does Cln1 
(Oehlen and Cross, 1994; Strickfaden et al., 2007). Thus, when Far1 
is absent, the weaker Far1-independent arrest mechanisms can be 
overridden by Cln2 or genetic changes that increase Clb5-Cdk ac-
tivity. When Far1 is present, the stronger inhibition of G1/S tran-
scription may dampen Clb5 accumulation to a degree such that Sic1 
is not needed for pheromone arrest. A comparison of these sce-
narios is illustrated in Supplemental Figure S1.
Finally, our findings reveal that robust G1 arrest is physiologically 
important, because if cell cycle entry occurs when cells are respond-
ing to pheromone, it can lead to irreversible, lethal effects. In par-
ticular, this was observed when far1∆ cln2∆ sic1∆ cells were exposed 
to pheromone; they were unable to arrest in G1, but they were nev-
ertheless unable to divide and grow. Similar inviability was observed 
during pheromone treatment of STE5–8A PGPD1-CLB5 cells, in which 
G1 arrest is bypassed but signaling cannot be shut down. The cause 
of this inviability is not known, but ongoing studies suggest that 
pheromone signaling disrupts the function of the microtubule cy-
toskeleton during nuclear division (unpublished observations). Our 
findings clarify earlier results that implied that Sic1 was not required 
for Far1-independent arrest: namely, pheromone was able to arrest 
growth of cln1∆ cln2∆ cln3∆ far1∆ sic1∆ cells (Tyers, 1996). In retro-
spect, those cells may not have arrested in G1 but instead became 
inviable due to failed G1 arrest. These notions also illuminate an 
important consideration when analyzing other mutants for defects in 
pheromone-mediated arrest: if they allow slippage past the G1/S 
transition but do not prevent pheromone signaling, then the G1 ar-
rest defect will not be noticeable by growth arrest assays. Hence it 
is conceivable that a distinct class of pheromone arrest mutants ex-
ists that would have gone undetected in prior genetic screens.
MATERIALS AND METHODS
Yeast strains and plasmids
Standard procedures were used for growth and genetic manipulation 
of yeast (Rothstein, 1991; Sherman, 2002). Yeast cultures were grown 
at 30°C. Strains and plasmids are listed in Tables 1 and 2, respec-
tively; all yeast strains were derived from the W303 background 
(Thomas and Rothstein, 1989) and harbored the bar1∆ mutation to 
block α factor degradation. PCR-mediated gene targeting used 
methods described previously (Longtine et al., 1998); selectable 
markers included antibiotic resistance genes (kanMX6, natMX6) and 
orthologues of biosynthesis genes from other yeasts (Saccharomyces 
kluyveri HIS3, Candida glabrata TRP1, Kluyveromyces lactis URA3). 
To ensure that genetic effects were reproducible, independently 
Whi5/Stb1 or the CKI Sic1, or even both Whi5 and Sic1 simultane-
ously, but these negative factors become important for pheromone 
arrest in far1∆ cells. The existence of multiple braking mechanisms 
may help to prevent premature cell cycle entry when antiprolifera-
tive signals are present and expand the commitment decision 
period, perhaps by imposing a requirement that G1/S Cdk activity 
exceeds a sufficiently high threshold to counteract multiple antago-
nists. Such functional overlap, while in principle not required for a 
basic cell cycle, may increase the opportunities for regulatory con-
trol. Indeed, in animals there is evidence that Rb and CKIs can have 
additive effects in restraining proliferation of undifferentiated cells or 
redundant effects in terminally differentiated cells (Brugarolas et al., 
1998; Buttitta et al., 2010; Wirt et al., 2010).
It is noteworthy that removal of Whi5 and Stb1 was not sufficient 
for full expression of G1/S transcripts, despite evident derepression. 
Instead, we found that pheromone signaling inhibits expression of 
G1/S genes even in the absence of both repressors, similar to previ-
ous results in whi5∆ or stb1∆ single mutants (Costanzo et al., 2004; 
de Bruin et al., 2008). Because this inhibition was maximal when 
Far1 was present, it suggests that Cdk activity promotes full G1/S 
transcription by an additional route separate from its role in releas-
ing repression by Whi5/Stb1, perhaps via direct phosphorylation of 
SBF and/or MBF. Indeed, Cdk sites have been identified in both 
Swi4 and Swi6, but direct evidence that Cdk phosphorylation of 
SBF/MBF enhances their activity is lacking (Sidorova et al., 1995; 
Wijnen et al., 2002); instead, mutational analyses suggest that Cdk 
phosphorylation of Swi6 or Whi5 acts redundantly to block repres-
sion (Costanzo et al., 2004; de Bruin et al., 2004; Wagner et al., 
2009). A further Cdk-regulated mechanism could affect the activity 
of SBF/MBF itself, an associated factor such as Msa1 (Ashe et al., 
2008), or a separate factor that cooperates with SBF/MBF such as 
Bck2 or Spt10 (Wijnen and Futcher, 1999; Eriksson et al., 2011). The 
existence of such a mechanism also fits with the finding that stabili-
zation of Tec1, which promotes CLN1 expression and hence Cln1-
Cdk activity, was able to increase escape from G1 arrest even when 
Whi5/Stb1 were already absent.
Although Whi5/Stb1 and Sic1 contribute to pheromone-induced 
arrest when Far1 is absent, it is not clear whether they are regulated 
by pheromone or function instead as constitutive inhibitors (see 
question marks in Figure 8). Because Sic1 can be phosphorylated 
and stabilized by another MAPK, Hog1 (Escote et al., 2004), a simi-
lar effect could be exerted by the pheromone-regulated MAPK, 
Fus3. It is unlikely that the identical mechanism is used because the 
Hog1-phosphorylated form of Sic1 was absent in pheromone-ar-
rested cells (Escote et al., 2004), but another study did observe par-
tial phosphorylation of the Sic1 N-terminus in pheromone-arrested 
cells (Koivomagi et al., 2011), although the sites and responsible ki-
nases are unknown. The effects of pheromone on G1/S transcription 
may be caused primarily by Far1-mediated inhibition of Cdk activity 
and MAPK-mediated degradation of Tec1, although it is conceiv-
able that MAPK phosphorylation of SBF/MBF or Whi5/Stb1 pro-
vides another route for inhibition. Other pertinent mechanisms may 
include pheromone-induced reduction in Cln protein levels (Val-
divieso et al., 1993) or reductions in total protein synthesis rates 
(Goranov et al., 2009; see question marks in Supplemental Figure 
S1), which may cause a rapid drop in the levels of short-lived cyclins 
and hence reduce cyclin-Cdk activity.
Which molecular targets can explain the escape phenotypes 
we obtained by inactivating inhibitory circuits in far1∆ cln2∆ cells? 
Ultimately, the key factor dictating whether cells can pass the G1/S 
transition despite the presence of pheromone may be acquisition of 
B-type Cdk activity, as pheromone cannot arrest cells in G1 if the 
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Name Relevant genotypea Source
PPY1716 MATa bar1 Zimmerman 
and Kellogg 
(2001)
PPY1748 MATa bar1 STE5-8A Strickfaden 
et al. (2007)
PPY1777 MATa bar1 far1∆::ADE2 Strickfaden 
et al. (2007)
PPY1789 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6
Strickfaden 
et al. (2007)
PPY1867 MATa bar1 cln2∆::kanMX6 This study
PPY1913 MATa bar1 HIS3::PGPD1-CLB5 Strickfaden 
et al. (2007)
PPY1918 MATa bar1 STE5-8A HIS3::PGPD1-
CLB5
Strickfaden 
et al. (2007)
PPY2013 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 PGAL1-CDC20::URA3Kl
This study
PPY2014 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 PGAL1-CDC20::URA3Kl
This study
PPY2019 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 mbp1∆::TRP1Cg 
PGAL1-CDC20::URA3Kl
This study
PPY2020 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 mbp1∆::TRP1Cg 
PGAL1-CDC20::URA3Kl
This study
PPY2043 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 sic1∆::TRP1Cg
This study
PPY2063 MATa bar1 PGAL1-CDC20::URA3Kl This study
PPY2064 MATa bar1 PGAL1-CDC20::URA3Kl This study
PPY2068 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 sic1∆::TRP1Cg PGAL1-
CDC20::URA3Kl
This study
PPY2069 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 sic1∆::TRP1Cg PGAL1-
CDC20::URA3Kl
This study
PPY2082 MATa bar1 far1∆::ADE2 PGAL1-
CDC20::URA3Kl
This study
PPY2083 MATa bar1 far1∆::ADE2 PGAL1-
CDC20::URA3Kl
This study
PPY2085 MATa bar1 sic1∆::TRP1Cg This study
PPY2087 MATa bar1 far1∆::ADE2 sic1∆::TRP1Cg This study
PPY2090 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 mbp1∆::TRP1Cg 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
PPY2091 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 mbp1∆::TRP1Cg 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
PPY2128 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 mbp1∆::TRP1Cg 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP137 MATa bar1 cln2∆::kanMX6 
stb1∆::natMX6 PGAL1-CDC20::URA3Kl
This study
Name Relevant genotypea Source
YPAP138 MATa bar1 cln2∆::kanMX6 
stb1∆::natMX6 PGAL1-CDC20::URA3Kl
This study
YPAP141 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 stb1∆::natMX6 PGAL1-
CDC20::URA3Kl
This study
YPAP142 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 stb1∆::natMX6 PGAL1-
CDC20::URA3Kl
This study
YPAP143 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 rpd3∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP144 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 rpd3∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP151 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 whi5∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP152 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 whi5∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP153 MATa bar1 cln2∆::kanMX6 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP156 MATa bar1 cln2∆::kanMX6 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP157 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 stb1∆::natMX6 
whi5∆::HIS3Sk
This study
YPAP161 MATa bar1 cln2∆::kanMX6 
stb1∆::natMX6 whi5∆::HIS3Sk
This study
YPAP165 MATa bar1 cln2∆::kanMX6 PGAL1-
CDC20::URA3Kl
This study
YPAP166 MATa bar1 cln2∆::kanMX6 PGAL1-
CDC20::URA3Kl
This study
YPAP167 MATa bar1 cln2∆::kanMX6 
stb1∆::natMX6 whi5∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP168 MATa bar1 cln2∆::kanMX6 
stb1∆::natMX6 whi5∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP171 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 stb1∆::natMX6 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP172 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 stb1∆::natMX6 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP203 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 rpd3∆::HIS3Sk 
whi5∆::TRP1Cg PGAL1-CDC20::URA3Kl
This study
YPAP204 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 rpd3∆::HIS3Sk 
whi5∆::TRP1Cg PGAL1-CDC20::URA3Kl
This study
YPAP208 MATa bar1 cln2∆::natMX6 sic1∆::TRP1Cg This study
TABLE 1: Yeast strains used in this study. 
 Continues
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Name Relevant genotypea Source
YPAP240 MATa bar1 cln2∆::kanMX6 
cdh1∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP241 MATa bar1 cln2∆::kanMX6 
cdh1∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP242 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 cdh1∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP243 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 cdh1∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP244 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 cdh1∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP245 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 cdh1∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
Name Alias Description Source
pPP680 pRS315 CEN/ARS LEU2 vector Sikorski and Hieter (1989)
pPP681 pRS316 CEN/ARS URA3 vector Sikorski and Hieter (1989)
pPP3025 pFA6a-URA3-PGAL1 PCR template for URA3Kl-PGAL1 promoter insertion This study
pPP4042 YCplac33-TEC1 CEN/ARS URA3 TEC1 Bao et al. (2004)
pPP4043 YCplac33-tec1-T273M CEN/ARS URA3 TEC1-T273M Bao et al. (2004)
pPP4050 pL-TEC1-WT CEN/ARS LEU2 TEC1 This study
pPP4051 pL-TEC1-T273M CEN/ARS LEU2 TEC1-T273M This study
TABLE 2: Plasmids used in this study.
Name Relevant genotypea Source
YPAP209 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 sic1∆::TRP1Cg 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP210 MATa bar1 far1∆::ADE2 
cln2∆::kanMX6 sic1∆::TRP1Cg 
whi5∆::HIS3Sk PGAL1-CDC20::URA3Kl
This study
YPAP236 MATa bar1 cln2∆::natMX6 
sic1∆::TRP1Cg PGAL1-CDC20::URA3Kl
This study
YPAP237 MATa bar1 cln2∆::natMX6 
sic1∆::TRP1Cg PGAL1-CDC20::URA3Kl
This study
YPAP238 MATa bar1 cln2∆::natMX6 
sic1∆::TRP1Cg whi5∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
YPAP239 MATa bar1 cln2∆::natMX6 
sic1∆::TRP1Cg whi5∆::HIS3Sk PGAL1-
CDC20::URA3Kl
This study
aAll strains are in the W303 background (ade2-1 his3-11,15 leu2-3112 trp1-1 ura3-1 can1). In the PGAL1-CDC20 strains, a cassette containing the URA3Kl marker and 
GAL1 promoter is inserted in place of the CDC20 promoter at the native CDC20 locus.
TABLE 1: Yeast strains used in this study. Continued
derived strains of identical genotype were tested in parallel, and the 
combined results were averaged. For cell synchronization, the pro-
moter of the essential cell cycle gene CDC20 was replaced with a 
regulated promoter (PGAL1) using a PCR-generated cassette marked 
with the K. lactis URA3 gene (URA3Kl).
Synchronous culture assays
To synchronize cell cultures, we placed the CDC20 gene under con-
trol of the GAL1 promoter (Cosma et al., 2001; Bean et al., 2005; 
Takahata et al., 2009). These PGAL1-CDC20 strains were grown asyn-
chronously in liquid YPGal medium (containing 2% galactose), and 
then cultures were arrested in M phase by pelleting and resuspend-
ing in YPD medium (2% glucose), followed by incubation for 3 h. 
Cultures were released from the M-phase block by two rounds of 
pelleting and washing in YPGal, resuspension in YPGal either with or 
without α factor (0.2 μM), and incubation (with shaking) for 0–240 
min. In experiments using TEC1 plasmids, before the arrest in YPD 
and release in YPGal, cultures were grown overnight in synthetic 
media (SC –Leu, with 2% raffinose and 2% galactose) to maintain 
selection for LEU2 plasmids.
Flow cytometry and budding assays
DNA content was measured by flow cytometry using previous 
methods (Haase and Reed, 2002; Strickfaden et al., 2007). Briefly, 
cell aliquots (0.5 ml) were harvested by centrifugation, resus-
pended in 0.3 ml water, fixed by addition of 0.7 ml of 100% etha-
nol, mixed by inversion, and incubated overnight at 4°C. Fixed 
cells were pelleted, washed once with water, resuspended in 0.5 ml 
of freshly prepared RNase solution (2 mg/ml RNase A in 50 mM 
Tris-HCl, pH 8.0, 15 mM NaCl), and incubated for 2 h at 36°C. They 
were then pelleted and resuspended in 0.2 ml of fresh proteinase 
solution (1 mg/ml proteinase K in 50 mM Tris-HCl, pH 8.0), incu-
bated for 1 h at 36°C, then pelleted and resuspended in 0.5 ml of 
buffer (50 mM Tris-HCl, pH 7.5), and stored at 4°C. Before analysis, 
suspensions were sonicated (10 pulses with a microtip probe), and 
then 50 μl was mixed with 1 ml of fresh Sytox Green solution (1 μM 
in 50 mM Tris-HCl, pH 7.5), gently vortexed, and analyzed with a 
FACScan flow cytometer (BD, Franklin Lakes, NJ). For experiments 
that were directly compared with each other, a uniform range of 
fluorescence values was defined for both the 2C peak (generally 
100–150 U) and the total (including 1C, 2C, and intermediate; 
generally 40–200 U), and then percentage 2C was calculated as 
100% × 2C/total.
To analyze cell cycle position by budding, cells aliquots (0.5 ml) 
were fixed by the addition of formaldehyde to 3.7% final concentra-
tion, incubated on a nutator (room temperature, 10 min), washed 
three times with phosphate-buffered saline (PBS), and resuspended 
in 500 μl of PBS. Fixed cells were spotted onto glass slides and 
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viewed microscopically to score budded and unbudded cells; for 
each experimental condition, 200 cells were counted.
mRNA preparation and RT-qPCR analysis
RNA was prepared as described previously (de Bruin et al., 2008) 
using an RNeasy Plus Mini Kit (74134; Qiagen, Valencia, CA). Cells 
(∼5 × 107) were harvested by centrifugation and frozen in liquid ni-
trogen. Cell pellets were resuspended in 400 μl of Qiagen RLT-plus 
buffer freshly supplemented with β-mercaptoethanol (10 μl/ml of 
buffer) and transferred to a microcentrifuge tube. Approximately 
400 μl of acid-washed glass beads was added, and cells were lysed 
by vortexing (four cycles of 1 min, interspersed with rest periods of 
3 min on ice). The tube was punctured at the bottom with a needle, 
placed in another tube, and centrifuged briefly (10 s) to transfer the 
lysate to the fresh tube. Then cell debris was removed by centrifu-
gation (2 min, full speed). The supernatant was loaded onto Qiagen 
gDNA Eliminator columns, and then mRNA was prepared according 
to the manufacturer’s instructions, diluted to equal concentrations 
(0.5 μg/μl), and stored at −70°C. cDNA was synthesized from the 
RNA samples using a SuperScript VILO cDNA synthesis kit (11754; 
Invitrogen, Carlsbad, CA) as per the manufacturer’s instructions, us-
ing ∼2 μg of RNA per reaction. Products were diluted to 2.5 ng/μl.
Quantitative real-time PCRs were performed using Power SYBR 
Green PCR Master Mix (4367659; Applied Biosystems, Foster City, 
CA). Reaction mixtures (15 μl) contained 7.5 μl of SYBR Green reac-
tion mix, 2 μl of primer mix (3 μM each primer), 1 μl of cDNA (2.5 ng), 
and 4.5 μl of water. Reactions were performed in 96-well plates, in 
duplicate, using an Applied Biosystems StepOnePlus instrument. 
Preliminary trials using multiple primers for each gene were per-
formed to identify primer sets with optimal properties (linearity of 
amplification) for use in all subsequent experiments. Primers are 
listed in Table 3. The ∆∆CT method was used to convert real-time 
amplification kinetics into relative mRNA levels; ACT1 mRNA served 
as the internal control.
Cell viability assays
Asynchronous cultures were treated with pheromone (0.2 μM) for 
1–4 h. Aliquots were collected before and after treatment, sonicated 
(seven pulses with a microtip probe), diluted in sterile PBS, spread 
Primer name Sequence (5′ to 3′)
CLN1-fw1 CTTTGGTTAGCGGCCAAAAC
CLN1-rev1 AGAAAGGCGTGGAATACGAG
YOX1-up1 AAATAGGCGCTCATCCACAC
YOX1-dn1 ACGTTTTCACGGGAGTCAAC
RNR1-up1 TCGAGGCTGCTTTAGAAACG
RNR1-dn1 GGCAACCAAGAAACAAGAGG
POL1-fw1 TGACATTTGCTCTGGTAGGC
POL1-rev1 CGGCTTATGCTCCTTTTCAC
CDC21-fw1 GGAACCCAGCTGATTTTGAC
CDC21-rev1 CGGATCCTTCTCCTTCTTTG
SIC1-fw1 CCAAAAGCCTTCACAGAACC
SIC1-rev1 GAGAGGTCATACCCATGTTCG
ACT1-fw1 TTCCAGCCTTCTACGTTTCC
ACT1-rev1 CCAGCGTAAATTGGAACGAC
TABLE 3: Oligonucleotide primers used for RT-qPCR analysis.
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Figure S1.  Detailed illustration of regulatory pathways contributing to either pheromone arrest or cell cycle entry. 
As in Figure 8, regulatory effects that inhibit or promote the G1/S transition are indicated in red or green, respectively.  In 
addition, inhibitory effects of Cln-Cdk activity on the pheromone pathway are indicated in blue.  The question marks indicate 
that, in addition to regulating Far1 and Tec1, the pheromone-activated MAPK may cause post-translational effects that 
interfere with the synthesis and/or stability of cyclin proteins (see Discussion). 
(A) The pheromone pathway and the cell cycle are mutually antagonistic.  In wild-type cells, the ability of pheromone to cause 
G1 arrest is likely dependent on whether the pheromone signal is received prior to the accumulation of Cln-Cdk activity. 
(B) In far1! CLN2 cells, uninhibited Cln-Cdk can more potently drive events that promote the G1/S transition (green arrows) 
and that inhibit pheromone signaling (blue inhibitory arrow), resulting in resistance to pheromone arrest. 
(C) In far1! cln2! cells, the loss of Cln2-Cdk activity can allow other pheromone-induced effects to effectively antagonize the 
G1/S transition, in a manner dependent on Tec1 destruction and the activities of Whi5/Stb1 and Sic1. 
